Centre of Excellence for Remote and Decentralised Clinical Trials

Trials@Home aims to reshape clinical trial design, conduct and operations, by developing and piloting standards, recommendations and tools for the definition and operationalisation of remote decentralised clinical trials (RDCTs) in Europe.

Centre of Excellence Remote and Decentralised Clinical Trials

Trials@Home aims to reshape clinical trial design, conduct and operations, by developing and piloting standards, recommendations and tools for the definition and operationalisation of remote decentralised clinical trials (RDCTs) in Europe.

*

Key objectives:

  • Defining the best practices for the conduct of RDCTs.

  • Identifying technologies and other operational innovative approaches for RDCTs and selecting the appropriate technology package to be used for the pan-EU pilot.

  • Designing and running a pan-EU pilot, comparing the scientific and operational quality of the RDCT with traditional trial approaches and evaluating the feasibility of the RDCT.

  • Identifying, mapping and analysing the relevant ethical, quality, regulatory, legal and organisational barriers and enablers of RDCTs.

  • Consulting with stakeholders and promoting the outcomes from the Trials@Home consortium through targeted communication, dissemination and training activities.

  • Providing recommendations with supporting tools for implementing RDCTs in Europe and contributing to the update of ICH guidelines on RDCTs.

More
*

About us

*

About RDCT’s

*

About the ESP & PEP

News & publications

*

RfP – Submit your technology now to complete the end-to-end RDCT technology package

21 December – Utrecht

In a collaboration with 31 international partners, Trials@Home will check the feasibility of fully remote Clinical Trials (RDCTs). For the execution of these RDCTs, technologies are needed. Some of them are already familiar and/or contracted by the Trials@Home partners, but other RDCT technologies are not and need to be introduced in this project and pilot study. We are looking for these technologies, and that’s why this Request for Proposals has been launched.

All the technologies are categorised in Basic Building Blocks (BBB) categories based on key functionalities within those building blocks, which are called activities. The scope of this RfP contains the following BBB’s / categories: Data Acquisition & Processing, Patient Engagement, Setup & Design, Closeout & Reporting, Operation & Coordination, and Recruit & Enroll. A description of these BBB’s and required technologies can be found in the ‘BBB profile’ documents on the Trials@Home website.

SUBMIT YOUR TECHNOLOGY

Join us: Postdoc IMI Trials@Home project

27 May 2021

Do you want to contribute to the reshaping of clinical trials? In this position you will play a central role in the development and execution of a technology-driven pan-EUR remote clinical trial in a large public-private consortium.

Click here to read the job description and to apply

Follow us on Twitter
Sign up for our Newsletter